Similar articles

• Prostaglandins XII: structure-activity relationship of some acetylenic-PGE2 derivatives.

  Franceschini J, Mizzotti B, Ceserani R, Mandelli V, Usardi MM. Franceschini J, et al. Pharmacol Res Commun. 1977 Nov;9(10):899-908. doi: 10.1016/s0031-6989(77)80099-4. Pharmacol Res Commun. 1977. PMID: 564517 No abstract available.
• Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.

  Crane BH, Maish TL, Maddox YT, Corey EJ, Székely I, Ramwell PW. Crane BH, et al. J Pharmacol Exp Ther. 1978 Jul;206(1):132-8. J Pharmacol Exp Ther. 1978. PMID: 351171 No abstract available.
• The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.

  Whittle BJ, Boughton-Smith NK, Moncada S, Vane JR. Whittle BJ, et al. J Pharm Pharmacol. 1978 Sep;30(9):597-9. doi: 10.1111/j.2042-7158.1978.tb13338.x. J Pharm Pharmacol. 1978. PMID: 29109 No abstract available.
• [Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application: digestive system diseases].

  Muto H. Muto H. Nihon Rinsho. 1985 Mar;43(3):583-6. Nihon Rinsho. 1985. PMID: 3892089 Review. Japanese. No abstract available.
• Effects of E2 prostaglandins on gastric secretion and gastrointestinal mucosa.

  Johansson C, Kollberg B. Johansson C, et al. Scand J Gastroenterol Suppl. 1980;58:93-7. Scand J Gastroenterol Suppl. 1980. PMID: 6988944 Review. No abstract available.